Read the FDA’s latest update on the risk MagSafe poses to pacemakers

It took a bit longer than expected due to the pandemic, but Apple finally announced the iPhone 12 last October during a prerecorded event at its Cupertino campus. Alongside the new phone models, Apple also pulled back the curtain on a series of MagSafe accessories that would be compatible with the iPhone 12. A few months later, doctors expressed their concerns about MagSafe technology's effect on pacemakers in the medical journal Heart Rhythm. Shortly after, Apple responded on its support site, and now, this week, the FDA has finally weighed in.

Citing articles warning that the high field strength magnets in new phones, watches, and other smart devices, the US Food and Drug Administration revealed in a news brief on Thursday that it decided to conduct its own testing to see if these magnets did indeed pose any risk to patients with implanted medical devices. Those tests showed that "the risk to patients is low," and adverse events associated with this technology have yet to be reported.